Spotlight on Paricalcitol in Secondary Hyperparathyroidism

Author： Robinson Dean M.   Scott Lesley J.  

Publisher： Adis International

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.4, Iss.3, 2005-01, pp. : 185-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol

By  

Current Vascular Pharmacology, Vol. 6, Iss. 2, 2008-04 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperparathyroidism Secondary to Hyperaldosteronism

By Fortina Felice  

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 1, 2010-03 ,pp. : 27-30

Adis International

Access to resources Recommend Favorite

Coeliac disease in subjects with secondary hyperparathyroidism

By Jorde R.   Saleh F.   Sundsfjord J.   Haug E.   Skogen B.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 2, 2005-02 ,pp. : 178-182

Informa Healthcare

Access to resources Recommend Favorite

Simultaneous medullary and papillary microcarcinoma of thyroid in a patient with secondary hyperparathyroidism

By Behrend Matthias   Wasielewski Reinhard   Brabant Georg  

Endocrine Pathology, Vol. 13, Iss. 1, 2002-03 ,pp. : 65-73

Humana Press, Inc

Access to resources Recommend Favorite

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl

By Eriguchi Rieko   Umakoshi Junko   Tominaga Yoshihiro   Sato Yuzuru  

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 218-220

Oxford University Press

Access to resources Recommend Favorite